Sigma Planning Corp’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-326
| Closed | -$4.32K | – | 1302 |
|
|
2023
Q2 | $4.32K | Sell |
326
-4,055
| -93% | -$53.7K | ﹤0.01% | 1197 |
|
|
2023
Q1 | $342K | Buy |
4,381
+82
| +2% | +$6.4K | 0.01% | 953 |
|
|
2022
Q4 | $358K | Buy |
4,299
+354
| +9% | +$29.5K | 0.01% | 895 |
|
|
2022
Q3 | $363K | Buy |
3,945
+3
| +0.1% | +$276 | 0.01% | 867 |
|
|
2022
Q2 | $590K | Sell |
3,942
-568
| -13% | -$85K | 0.02% | 689 |
|
|
2022
Q1 | $1.09M | Buy |
4,510
+20
| +0.4% | +$4.85K | 0.03% | 500 |
|
|
2021
Q4 | $1.36M | Sell |
4,490
-66
| -1% | -$20K | 0.04% | 427 |
|
|
2021
Q3 | $1.88M | Buy |
4,556
+58
| +1% | +$24K | 0.06% | 341 |
|
|
2021
Q2 | $1.38M | Buy |
4,498
+1,553
| +53% | +$476K | 0.04% | 437 |
|
|
2021
Q1 | $605K | Buy |
2,945
+46
| +2% | +$9.45K | 0.02% | 686 |
|
|
2020
Q4 | $580K | Buy |
2,899
+136
| +5% | +$27.2K | 0.02% | 632 |
|
|
2020
Q3 | $457K | Buy |
2,763
+494
| +22% | +$81.7K | 0.02% | 632 |
|
|
2020
Q2 | $563K | Buy |
2,269
+1,085
| +92% | +$269K | 0.02% | 552 |
|
|
2020
Q1 | $216K | Buy |
+1,184
| New | +$216K | 0.01% | 752 |
|